Quality of life in patients with choroidal melanoma;Calidad de vida en pacientes con melanoma de coroides

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 83, Issue 5, 2008, Pages 301-306

  Blanco Rivera, Ma Carmen ^a,b,d   Capeans Tome C ^a   Otero Cepeda, X L ^a,c  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d NONE   (Spain)

Author keywords

Brachytherapy; Choroidal melanoma; Enucleation; Quality of life; VF 14

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; BRACHYTHERAPY; CHOROID TUMOR; ENUCLEATION; FEMALE; HUMAN; MALE; MELANOMA; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE;

BRACHYTHERAPY; CHOROID NEOPLASMS; EYE ENUCLEATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MELANOMA; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 45849112864     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cruickshanks KJ, Fryback DG, Nondahl DM , Robinson N, Keesey U, Dalton DS, et al. Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol 1999; 117: 461-467.
2. Capeans C. Melanomas de la úvea. Madrid: Sociedad Española de Oftalmología; 1993.
3. Singh AD, Rennie IG, Kivela T, Seregard S, Grossniklaus H. The Zimmerman-McLean-Foster hypothesis: 25 years later. Br J Ophthalmol 2004; 88: 962-967.
4. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre- enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no 10. Am J Ophthalmol 1998; 125: 779-796.
5. Diener-West M, Earle JD, Fine SL, Hawkins BS, Moy CS, Reynolds SM, et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18. Arch Ophthalmol 2001; 119: 969-982.
6. Reimer J, Esser J, Fleiss A, Hessel A, Anastassiou G, Krausz M, et al. Quality of life in patients with malignant choroidal melanoma after radiotherapy. Graefes Arch Clin Exp Ophthalmol 2003; 241: 371-377.
7. Melia MB, Moy SC, McCaffrey L. Quality of life in patients wiht choroidal melanoma: a pilot study. Ophthalmic Epidemiol 1999; 6: 19-28.
8. Quality of life assessment in the collaborative ocular melanoma study: desing and methods. COMS-QOLS Report No. 1. COMS Quality of Life Study Group. Ophthalmic Epidemiol 1999; 6: 5-17.
9. Melia M, Moy CS, Reynolds SM, Cella D, Murray TG, Hovland KR, et al. Development and validation of disease-specific measures for choroidal melanoma: COMS-QOLS report No. 2. Arch Ophthalmol 2003; 121: 1010-1020.
10. Melia M, Moy CS, Reynolds SM, Hayman JA, Murray TG, Hovland KR, et al. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Study: COMS QOLS Report No 3. Arch Ophthalmol 2006; 124: 226-238.
11. Casado J, González N, Moraleda S, Orueta R, Carmona J, Gómez-Calcerrada RM. Calidad de vida relacionada con la salud en pacientes ancianos en atención primaria. Aten Primaria 2001; 28: 167-173.
12. Prieto L, Prieto L, Badía X. Cuestionarios de salud: concepto y metodología. Aten Primaria 2001; 28: 201-209.
13. Blanco-Rivera MC. Calidad de vida en pacientes tratados de melanoma de coroides. Santiago de Compostela: Universidad de Santiago de Compostela. 2005; 198 pp. Thesis doctoralis.
14. Linder M, Chang TS, Scott IU, Hay D, Chambers K, Sibley LM, et al. Validity of the visual function index (VF-14) in patients with retinal disease. Arch Ophthalmol 1999; 117: 1611-1616.
15. Melia BM, Abramson DH, Albert DM, Boldt HC, Earle JD, Hanson WF, et al. Collaborative Ocular Melanoma Study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma, I. Visual acuity after 3 years COMS report no. 16. Ophthalmology 2001; 108: 348-366.
16. Shields CL, Shields JA, Carter J, Gündüz K, Miyamoto C, Micaily B, et al. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients. Arch Ophthalmol 2000; 118: 1219-1228.